Phase I/II Trial of Oral Bexarotene in Combination with Cisplatin and Irinotecan in Patients with Extensive Stage Small Cell Lung Cancer

Arnold, Suzanne (PI)

Markey Cancer Center / Cancer Research Priority Initiative

Status	Finished
Effective start/end date	9/1/04 → 4/30/05

Funding

Ligand Pharmaceuticals Inc

1 Finished

A Pharmacokinetic/Pharmacodynamic Study of Oral Bexarotene with Cisplatin and Irinotecan in Extensive Stage Small Cell Lung Cancer
Davis, G. (PI) & Adams, V. (CoI)
Ligand Pharmaceuticals Inc
9/1/04 → 4/30/05
Project: Research project